Mirai Bio Expands LNP Delivery Into Adipocyte Tissue
CAMBRIDGE, Mass., May 14, 2026 Mirai Bio presented new preclinical data at the American Society of Gene and Cell...
ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
CAMBRIDGE, Mass., May 14, 2026 Mirai Bio presented new preclinical data at the American Society of Gene and Cell...
CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...
ESSEN/MUNICH, Germany, September 9, 2025 – Evonik and Ethris have entered a strategic partnership to enhance RNA-based therapeutic solutions...
